It's bad enough that annual flu vaccines are often ineffective, but now we learn that the more popular, needle-free "FluMist" influenza vaccine has not provided protection for kids or adults for several years, and therefore should not be used in the coming flu season, say experts.
As reported by NBC News, the recommendation to forego the FluMist vaccine may also leave doctors short of vaccine altogether, according to the Centers for Disease Control and Prevention (not a bad thing, we believe).
"Nasal spray flu vaccine accounts for about one-third of all flu vaccines given to children," CDC said in a statement.
Flu vaccines are already among some of the most ineffective of all vaccines, simply because it is impossible to make a flu vaccine that matches circulating strains of influenza for the season, because they can, and often do, change every year.
FluMist utilizes live, but weakened, flu strains to stimulate the body's immune system. It is sprayed directly up the nose. In some seasons it had been reported that it was much more effective than the flu vaccine given via syringe.
Not so, apparently. The Advisory Committee on Immunization Practices examined data from the past couple of flu seasons and discovered that FluMist has not worked much at all. The CDC said that the spray was only about 3 percent effective during the most recent flu season.
"This 3 percent estimate means no protective benefit could be measured," the CDC said, adding that the agency was not sure why the spray was not effective.
"In comparison, inactivated influenza vaccine (flu shots) had a vaccine effectiveness estimate of 63 percent against any flu virus among children 2 years through 17 years," the CDC said – which is still not a great percentage.
As you might expect, the FluMist maker, MedImmune – owned by AstraZeneca – disputed the CDC's findings.
"These findings demonstrate FluMist Quadrivalentwas 46-58 percent effective overall against the circulating influenza strains during the 2015-2016 season," the company said in a statement.
Of course, if you want to keep selling a flu vaccine, then you would dispute any research that found it ineffective, wouldn't you?
Despite the fact that these vaccines are not effective, however, the CDC – like a robot, or a parrot – is continuing to recommend that everyone get a flu shot each year anyway. The big lie being pushed is that even with an ineffective flu vaccine in their systems, vaccinated people are less likely to get the flu (says the agency), which makes the CDC sound like a propaganda mill rather than an institution disseminating unbiased scientific research.
"How well the flu vaccine works (or its ability to prevent flu illness) can range widely from season to season and can be affected by a number of factors, including characteristics of the person being vaccinated, the similarity between vaccine viruses and circulating viruses, and even which vaccine is used," the CDC said.
"CDC will be working with manufacturers throughout the summer to ensure there is enough vaccine supply to meet the demand," it added. "Vaccine manufacturers had projected that as many as 171 million to 176 million doses of flu vaccine, in all forms, would be available for the United States during the 2016-2017 season. The makers of (FluMist) had projected a supply of as many as 14 million doses of nasal spray flu vaccine, or about 8 percent of the total projected supply."
And, with a view to generating more profits, AstraZeneca announced that it would continue to manufacture and distribute its ineffective FluMist spray in other countries whose populations are likely unaware of its ineffectiveness.
"AstraZeneca is working with the CDC to better understand its data to help ensure eligible patients continue to receive the vaccine in future seasons in the U.S.," it said.
Of course.
Sources:
NBCNews.com
NaturalNews.com
FOXNews.com
Science.NaturalNews.com
Just days ago, an advisory committee of the US Centers for Disease Control and Prevention (CDC) voted against using the popular FluMist nasal spray vaccine for the upcoming flu season campaign due to its extreme ineffectiveness.
The CDC’s vaccine task force, known as the Advisory Committee on Immunization Practices (ACIP) announced that the live attenuated vaccine was only three percent effective in children ages 2 through 17. This panel of vaccine experts stated that “no protective benefit could be measured.” In the general population, overall flu vaccine effectiveness was only 49 percent. [1]
The American Academy of Pediatrics has already formally supported the recommendation to halt the use of the nasal spray flu vaccine. [2]
This vote of no confidence in the nasal spray flu vaccine comes after three seasons of inefficacy.
The nasal spray flu vaccine, known in medical circles as live attenuated influenza vaccine (LAIV) and known by the public as FluMist, was first licensed in 2003 as a three-in-one vaccine. Since then, according to the manufacturer, 116 million doses have been distributed around the world. [3]
So far, it is the only non-injection based vaccine against influenza on the market. US Sales of the FluMist vaccine during fiscal year 2015 were $206 million, with global sales of $290 million.
Data suggests that up to one third of children who are vaccinated against the flu previously used the nasal spray version. The nasal spray vaccine was supposed to supply eight percent of the US total expected flu vaccine doses in the coming flu season.
Data from the CDC shows that in previous flu seasons, the nasal spray flu vaccine has been ineffective at preventing the flu in children. During the 2013-14 flu season, it showed “no measurable effectiveness.” During the 2014-2015 flu season, it showed that “neither vaccine worked well” against the flu in children ages two through eight. [4]
Even more shockingly, the CDC admits on its own website that flu vaccines are ineffective in preventing the flu in children. “Since CDC began measuring vaccine effectiveness in 2004-2005, estimates [of effectiveness] have ranged from 10% to 60%.”
AstraZeneca, the manufacturer of FluMist, disputed the CDC’s findings, yet they only claimed a 48-56 percent effectiveness using their nasal spray vaccine against influenza during the most recent flu season.
This live vaccine also carries the ability to “shed” the flu virus from someone who has received the nasal spray vaccine to another individual. A study was conducted among children in a daycare setting, and the likelihood of acquiring a flu virus from a child who had received the nasal spray vaccine was estimated to be 2.4 percent. Due to shedding concerns, these nasal spray flu vaccines could have theoretically caused more cases of the flu than they actually prevented. [5]
Dr. Margot Savoy, a member of the American Academy of Family Physicians, cautioned fellow physicians, “You should not use the LAIV you preordered for anyone (adults or children) … This vote leaves no room for using LAIV in any population.” [6]
A search of the Vaccine Adverse Event Reporting System (VAERS) shows that 2,893 total adverse events have been reported with use of the FluMist live attenuated influenza vaccine. [7]
Ironically, in their press release, the CDC stated, “Today’s ACIP vote highlights the importance of measuring and evaluating the effectiveness of public health interventions.”
Finally, after years of data cannot hide the lack of efficacy, even government and professional organizations are taking note: flu vaccines don’t work.
Informed parents know there are safer and more effective ways to keep their children healthy, without injecting their sons and daughters with vaccines and the associated toxic ingredients.
Do you vaccinate your child or yourself against the flu? How do you promote good health in your family during the winter months? Please share your comments below and share the important information in this article with others!
References:
www.naturalblaze.com/2016/06/cdc-halts-use-of-nasal-spray-flu-vaccine.html